GCG and type 2 diabetes mellitus: In view of the therapeutic success of current GLP-1 based strategies in treatment of T2DM, the prospect to harness endogenous GLP-1 production from enteroendocrine L cells using a targeted approach has emerged (Albrechtsen et al.